2-188993362-G-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP2PP3PP5_Very_Strong
The NM_000090.4(COL3A1):c.1052G>T(p.Gly351Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 15/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G351S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000090.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL3A1 | NM_000090.4 | c.1052G>T | p.Gly351Val | missense_variant, splice_region_variant | Exon 16 of 51 | ENST00000304636.9 | NP_000081.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL3A1 | ENST00000304636.9 | c.1052G>T | p.Gly351Val | missense_variant, splice_region_variant | Exon 16 of 51 | 1 | NM_000090.4 | ENSP00000304408.4 | ||
| COL3A1 | ENST00000450867.2 | c.1050+422G>T | intron_variant | Intron 15 of 49 | 1 | ENSP00000415346.2 | ||||
| COL3A1 | ENST00000713745.1 | c.1052G>T | p.Gly351Val | missense_variant, splice_region_variant | Exon 16 of 49 | ENSP00000519049.1 | ||||
| COL3A1 | ENST00000713744.1 | c.1052G>T | p.Gly351Val | missense_variant, splice_region_variant | Exon 16 of 49 | ENSP00000519048.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1414690Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 699056
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, type 4 Pathogenic:3
COL3A1 NM_000090.3 exon 16 p.Gly351Val (c.1052G>T): This variant has been reported in the literature in 2 individuals with features suggestive of or consistent with vascular Ehlers-Danlos syndrome (Pepin 2014 PMID:24922459; Lumi 2021 PMID:34011391). This variant is absent from large control databases but is present in ClinVar (Variation ID:101195). Evolutionary conservation and computational prediction tools suggest that this variant impacts the protein. Of note, this variant alters a Glycine in the Gly-X-Y repeat sequence of COL3A1's triple-helical region; Glycine residues at these positions are known to be critical for proper protein structure and stability (Mizuno 2013 PMID:23645670). In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant is classified as likely pathogenic. -
- -
- -
Ehlers-Danlos syndrome, type 4;C5193040:Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome Pathogenic:1
This variant has been reported in the literature in 2 individuals with features suggestive of or consistent with vascular Ehlers-Danlos syndrome (Pepin 2014 PMID:24922459; Lumi 2021 PMID:34011391). This variant is absent from large control databases but is present in ClinVar (Variation ID:101195). Evolutionary conservation and computational prediction tools suggest that this variant impacts the protein. Of note, this variant alters a Glycine in the Gly-X-Y repeat sequence of COL3A1's triple-helical region; Glycine residues at these positions are known to be critical for proper protein structure and stability (Mizuno 2013 PMID:23645670). In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant is classified as likely pathogenic. -
not provided Pathogenic:1
Identified in unrelated patients with vEDS in the published literature (PMID: 24922459, 34011391, 20707836); Occurs in the triple helical domain and replaces the glycine in the canonical Gly-X-Y repeat; missense substitution of a canonical glycine residue is expected to disrupt normal protein folding and function, and this is an established mechanism of disease (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as p.G184V; This variant is associated with the following publications: (PMID: 38174045, 24922459, 34011391, 20707836) -
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome Pathogenic:1
This variant was classified as: Likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at